Alexandria Venture Investments was among the participants in a series A for the cellular cancer therapeutics developer based on work at Institut Curie and Memorial Sloan Kettering.

Mnemo Therapeutics, a France-based cellular therapeutics developer advancing research from Institut Curie and Memorial Sloan Kettering Cancer Center, closed a €75m ($91m) series A round on Wednesday led by Casdin Capital. Alexandria Venture Investments, a vehicle for life sciences real estate investment trust Alexandria Real Estate Equities, backed the round, as did Redmile, Emerson Collective…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.